Oramed Pharmaceuticals Inc. (ORMP) Statistics & Valuation Metrics - Stocknear

Oramed Pharmaceuticals In...

NASDAQ: ORMP · Real-Time Price · USD
2.23
0.01 (0.45%)
At close: Sep 05, 2025, 3:56 PM
2.18
-2.02%
After-hours: Sep 05, 2025, 04:45 PM EDT

Oramed Pharmaceuticals Statistics

Share Statistics

Oramed Pharmaceuticals has 40.82M shares outstanding. The number of shares has increased by 0.2% in one year.

40.82M
0.2%
1.34%
19%
32.89M
1,347
1.92%

Short Selling Information

The latest short interest is 364.45K, so 0.89% of the outstanding shares have been sold short.

364.45K
0.89%
1.02%
5.73

Valuation Ratios

The PE ratio is -5.17 and the forward PE ratio is -1.76. Oramed Pharmaceuticals's PEG ratio is 0.01.

-5.17
-1.76
0
n/a
0.68
-11.72
0.01
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Oramed Pharmaceuticals.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 25.19, with a Debt / Equity ratio of 0.

25.19
25.19
0
-0.03
-0.04
-14.98

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-1.47M
13
0
n/a

Taxes

3.18M
-19.99%

Stock Price Statistics

The stock price has increased by -5.11% in the last 52 weeks. The beta is 1.68, so Oramed Pharmaceuticals's price volatility has been higher than the market average.

1.68
-5.11%
2.14
2.25
60
70,025

Income Statement

n/a
-193K
-12.78M
-19.1M
-14.87M
-15.07M
-0.47
Full Income Statement

Balance Sheet

The company has 54.42M in cash and 372K in debt, giving a net cash position of 54.05M.

54.42M
372K
54.05M
-176.62M
161.68M
95.33M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.41M and capital expenditures -18K, giving a free cash flow of -8.43M.

-8.41M
-18K
-8.43M
-0.21
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

ORMP does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for ORMP.

n/a
n/a
n/a
n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Jan 23, 2013. It was a backward split with a ratio of 1:12.

Jan 23, 2013
backward
1:12

Scores

5.72
2